移植
诱导多能干细胞
细胞生物学
干细胞
体外
原位
再生医学
细胞疗法
血管生成
化学
细胞
心脏移植
胚胎干细胞
癌症研究
神经科学
电生理学
内皮干细胞
细胞培养
缝隙连接
药理学
人诱导多能干细胞
生物
基质(化学分析)
体内
细胞生长
干细胞疗法
心脏细胞
细胞外基质
组织工程
细胞迁移
医学
作者
Xueqin Shi,Jianfeng Zhong,Xueting Liu,Shuai Guo,Weirun Li,Jiexin Zhang,Xiaodong Ning,Yuhua Liu,Chi Zhang,Qiujian Zhong,Zhilong Zhang,Tianwang Guan,Peier Chen,Caiwen Ou
标识
DOI:10.1002/adhm.202503799
摘要
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have demonstrated significant potential for the treatment of heart diseases. However, hiPSC-CMs generated by the current methods still exhibit structural and electrophysiological immaturity, resembling fetal cardiomyocytes. Although various strategies have been developed to promote in vitro maturation, cell loss and death remain persistent challenges during transplantation. Therefore, a multipronged approach is developed to induce in situ hiPSC-CMs functional maturation and enhance the cell transplantation rate, not only allowing cells carried within to have lower automatism, but also retaining the ability to restore systolic function. Chitosan is used as the matrix backbone to form a unique 3D network structure for cell encapsulation and delivery, whereas anionic lipid-based carriers derived from negatively charged liposomes enabled pH-responsive release of the mammalian target of rapamycin (mTOR) inhibitor within the weakly acidic microenvironment in myocardial infarction. Inhibition of the mTOR-signaling pathway can promote the functional maturation of hiPSC-CMs by bringing them into a quiescent state, allowing the cells not only to have lower automatism but also to resume pulsation under slight stimulation. This approach promotes the functional recovery of injured hearts by enhancing more robust gap junctions and angiogenesis in infarcted mouse hearts.
科研通智能强力驱动
Strongly Powered by AbleSci AI